Sections

Gynecologic Myomectomy

Workup

Diagnostic Studies and Procedures

Laboratory studies

Recommended laboratory studies are as follows:

Pregnancy test: No patient should have a myomectomy until the possibility of pregnancy is excluded
A preoperative hemoglobin level should be obtained

Imaging studies

Ultrasonography

Uterine leiomyoma can usually be detected on pelvic examination. If any doubt remains or if the uterine enlargement must be confirmed or differentiated from a pelvic mass, ultrasonography is very useful. Leiomyomas can also be detected with CT scanning or MRI, but, in general, these tests are more expensive and do not help visualize the uterus as well as ultrasonography does.

HSG or sonohysterography

In the evaluation of the endometrial cavity, if a strong possibility exists that myomas are present within the endometrial cavity, an HSG or sonohysterography can aid in localization. This allows the preoperative detection of myomas that may be more amenable to hysteroscopic resection and may thereby preclude the need to enter the endometrial cavity during an abdominal procedure.

MRI

Myomectomy is possible only for myomas; therefore, one must reasonably believe that the uterine enlargement is from leiomyoma and not from adenomyosis. The presence of myomas can usually be confirmed based on ultrasonography or physical examination findings by the characteristic irregularities of a uterus with multiple fibroids. If any doubt remains, MRI has been found useful in differentiating leiomyoma from adenomyosis.^{[17, 18]}

Diagnostic procedure

Endometrial biopsy

Myomectomy is not an acceptable option if the patient has an endometrial malignancy. An endometrial biopsy should be performed prior to performing myomectomy in any patient older than 35 years who has a history of irregular bleeding.

Treatment & Management

Speert H. Obstetrics and Gynecology in America: A History. Chicago, Ill: American College of Obstetrics and Gynecology; 1980.
Hutchins FL Jr. Abdominal myomectomy as a treatment for symptomatic uterine fibroids. Obstet Gynecol Clin North Am. 1995 Dec. 22(4):781-9. [Medline].
Wallach EE, Vlahos NF. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol. 2004 Aug. 104(2):393-406. [Medline].
Day Baird D, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan. 188(1):100-7. [Medline].
Schwartz SM. Epidemiology of uterine leiomyomata. Clin Obstet Gynecol. 2001 Jun. 44(2):316-26. [Medline].
Keshavaraz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy surveillance -- United States, 1994-1999. MMWR Suvveillance Summaries. 2002. 51:(SS05):1-8. [Full Text].
Greenberg MD, Kazamel TI. Medical and socioeconomic impact of uterine fibroids. Obstet Gynecol Clin North Am. 1995 Dec. 22(4):625-36. [Medline].
Becker ER. National trends and determinants of hospitalization costs and lengths-of-stay for uterine fibroids procedures. J Health Care Finance. 2007. 33(3):1-16. [Medline].
Walker C, Stewart E. Uterine Fibroids: The Elephant in the Room. Science. Jun 2005. 308:1589-1592. [Medline].
LevGur M, Levie MD. The myomatous erythrocytosis syndrome: a review. Obstet Gynecol. 1995 Dec. 86(6):1026-30. [Medline].
Iverson RE Jr, Chelmow D, Strohbehn K, et al. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas. Obstet Gynecol. 1996 Sep. 88(3):415-9. [Medline].
Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2012 Nov 14. 11:CD003857. [Medline].
Stovall DW, Parrish SB, Van Voorhis BJ, et al. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod. 1998 Jan. 13(1):192-7. [Medline].
Eldar-Geva T, Meagher S, Healy DL, et al. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril. 1998 Oct. 70(4):687-91. [Medline].
Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet. 2005 Nov. 273(1):50-4. [Medline].
Jayakrishnan K, Menon V, Nambiar D. Submucous fibroids and infertility: Effect of hysteroscopic myomectomy and factors influencing outcome. J Hum Reprod Sci. 2013 Jan. 6(1):35-9. [Medline].
Arnold LL, Ascher SM, Schruefer JJ, Simon JA. The nonsurgical diagnosis of adenomyosis. Obstet Gynecol. 1995 Sep. 86(3):461-5. [Medline].
Murase E, Siegelman ES, Outwater EK, et al. Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics. 1999 Sep-Oct. 19(5):1179-97. [Medline].
Alternative to Hysterectomy in the Management of Uterine Leiomyomas. August 2008;
Wu T, Chen X, Xie L. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. Cochrane Database of Systmatic Reviews. 2007. [Medline].
Moss J, Cooper K, Khaund A, Murray L, Murray G, Wu O, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG. 2011 Apr 12. [Medline].
Seinera P, Arisio R, Decko A, et al. Laparoscopic myomectomy: indications, surgical technique and complications. Hum Reprod. 1997 Sep. 12(9):1927-30. [Medline].
Hasson HM, Rotman C, Rana N, et al. Laparoscopic myomectomy. Obstet Gynecol. 1992 Nov. 80(5):884-8. [Medline].
Darai E, Dechaud H, Benifla JL, et al. Fertility after laparoscopic myomectomy: preliminary results. Hum Reprod. 1997 Sep. 12(9):1931-4. [Medline].
Dubuisson JB, Chapron C, Fauconnier A, Kreiker G. Laparoscopic myomectomy and myolysis. Curr Opin Obstet Gynecol. 1997 Aug. 9(4):233-8. [Medline].
Hurst BS, Matthews ML, Marshburn PB. Laparoscopic myomectomy for symptomatic uterine myomas. Fertil Steril. 2005 Jan. 83(1):1-23. [Medline].
Palomba S, Zupi E, Falbo, A, et al. A multicenter randomized, controlled study comparing laparoscopic versus minilaparotomic myomectomy: reproductive outcomes. Fertility and Sterility. Oct 2007. 88:933-941. [Medline].
Lowes R. FDA Toughens Power Morcellation Warning. Medscape Medical News. Available at https://www.medscape.com/viewarticle/835375. November 24, 2014; Accessed: June 11, 2018.
Stentz NC, Cooney LG, Sammel M, Shah DK. Changes in Myomectomy Practice After the U.S. Food and Drug Administration Safety Communication on Power Morcellation. Obstet Gynecol. 2017 Jun. 129 (6):1007-1013. [Medline].
Uterine Morcellation for Presumed Leiomyomas: ACOG Committee Opinion Summary, Number 822. Obstet Gynecol. 2021 Mar 1. 137 (3):552-3. [Medline]. [Full Text].
Di Spiezio Sardo A, Mazzon I, Bramante S, et al. Hysteroscopic myomectomy: a comprehensive review of surgical techniques. Hum Reprod Update. Mar-Apr 2008. 14:101-19. [Medline].
Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001. CD000547. [Medline].
Deligdisch L, Hirschmann S, Altchek A. Pathologic changes in gonadotropin releasing hormone agonist analogue treated uterine leiomyomata. Fertil Steril. 1997 May. 67(5):837-41. [Medline].
Celik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril. 2003 May. 79(5):1207-10. [Medline].
Nezhat C, Nezhat F, Silfen SL, et al. Laparoscopic myomectomy. Int J Fertil. 1991 Sep-Oct. 36(5):275-80. [Medline].
Dubuisson JB, Chapron C. Laparoscopic myomectomy today. A good technique when correctly indicated. Hum Reprod. 1996 May. 11(5):934-5. [Medline].
Parker WH, Rodi IA. Patient selection for laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1994 Nov. 2(1):23-6. [Medline].
Sinha R, Hegde A, Warty N, Patil N. Laparoscopic excision of very large myomas. J Am Assoc Gynecol Laparosc. 2003 Nov. 10(4):461-8. [Medline].
Choi CH, Kim TH, Kim SH, Choi JK, Park JY, Yoon A. Surgical outcomes of a new approach of laparoscopic myomectomy: single port and modified suture technique. J Minim Invasive Gynecol. 2013 Dec 30. [Medline].
Pluchino N, Litta P, Freschi L, Russo M, Simi G, Santoro AN. Comparison of the initial surgical experience with robotic and laparoscopic myomectomy. Int J Med Robot. 2013 Oct 3. [Medline].
Zullo F, Pellicano M, De Stefano R, et al. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors. Am J Obstet Gynecol. 1998 Jan. 178(1 Pt 1):108-12. [Medline].
Campo S, Garcea N. Laparoscopic myomectomy in premenopausal women with and without preoperative treatment using gonadoptropin-releasing hormone analogs. Human Reproduction. Jan 1999. 14:44-48. [Medline].
Cohen LS, Valle RF. Role of vaginal sonography and hysterosonography in the endoscopic treatment of uterine myomas. Fertil Steril. Feb 2000. 73:197-204. [Medline].
Perino A, Chianchiano N, Petronio M, et al. Role of leuprolide acetate depot in hysteroscopic surgery: a controlled study. Fertil Steril. Mar 1993. 59:507-10. [Medline].
Parazzini F, Vercellini P, De Giorgi O, et al. Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: literature review. Human Reproduction. Sep 1998. 13:2592-7. [Medline].
Donnez J, Polet R, Smets M, et al. Hysteroscopic myomectomy. Curr Opin Obstet Gynecol. Aug 1995. 7:311-6. [Medline].
Campo S, Campo V, Gambadauro P. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Acta Obstet Gynecol Scand. Aug 2005. 84:756-760. [Medline].
Jansen FW, Vredevoogd CB, van Ulzen K, et al. Complications of hysteroscopy: a prospective, multicenter study. Obstet Gynecol. Aug 2006. 96:266-70. [Medline].
Propst AM, Liberman RF, Harlow BL, et al. Complications of hysteroscopic surgery: predicting patients at risk. Obstet Gynecol. Oct 2000. 96:517-20. [Medline].
Agostini A, Cravello L, Shojai R, et al. Postoperative infection and surgical hysteroscopy. Fertility and Sterility. Apr 2002. 77:766-768. [Medline].
Antibiotics for Gynecologic Procedures. November 2009;
Preutthipan S, Herabutya Y. A randomized comparison of vaginal misoprostol and dinoprostone for cervical priming in nulliparous women before operative hysteroscopy. Fertil Steril. Oct 2006. 86:990-4. [Medline].
Wheeless CR. Atlas of Pelvic Surgery. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1997.
Rock JA, Jones HW. Te Linde's Operative Gynecology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008.
Frederick J, Fletcher H, Simeon D, et al. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol. 1994 May. 101(5):435-7. [Medline].
DeLancey JO. A modified technique for hemostasis during myomectomy. Surg Gynecol Obstet. 1992 Feb. 174(2):153-4. [Medline].
Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol. 1996 Jun. 87(6):1014-8. [Medline].
Ginsburg ES, Benson CB, Garfield JM, et al. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomized study. Fertil Steril. 1993 Dec. 60(6):956-62. [Medline].
Kongnyuy E, Wiysonge C. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database of Systematic Reviews. 2007. [Medline].
Tulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second- look laparoscopy. Obstet Gynecol. 1993 Aug. 82(2):213-5. [Medline].
Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D. Barrier agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev. 2000. CD000475. [Medline].
Carter JE, McCarus SD. Laparoscopic myomectomy. Time and cost analysis of power vs. manual morcellation. J Reprod Med. 1997 Jul. 42(7):383-8. [Medline].
Nezhat C, Nezhat F, Bess O, et al. Laparoscopically assisted myomectomy: a report of a new technique in 57 cases. Int J Fertil Menopausal Stud. 1994 Jan-Feb. 39(1):39-44. [Medline].
Zreik TG, Rutherford TJ, Palter SF, et al. Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids. J Am Assoc Gynecol Laparosc. 1998 Feb. 5(1):33-8. [Medline].
Goldfarb HA. Laparoscopic coagulation of myoma (myolysis). Obstet Gynecol Clin North Am. 1995 Dec. 22(4):807-19. [Medline].
Goldfarb HA. Nd:YAG laser laparoscopic coagulation of symptomatic myomas. J Reprod Med. 1992 Jul. 37(7):636-8. [Medline].
Peacock K, Hurst BS. Laparoscopic Myomectomy. Surgical Technology International. 2006. 15:141-145. [Medline].
Parker W. Uterine myomas: management. Fertility and Sterility. Aug 2007. 88:255-271. [Medline].
Nezhat FR, Roemisch M, Nezhat CH, et al. Recurrence rate after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 1998 Aug. 5(3):237-40. [Medline].
Pundir J, Pundir V, Walavalkar R, Omanwa K, Lancaster G, Kayani S. Robotic-assisted laparoscopic vs abdominal and laparoscopic myomectomy: systematic review and meta-analysis. J Minim Invasive Gynecol. 2013 May-Jun. 20(3):335-45. [Medline].
Seracchioli R, Rossi S, Govoni F, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod. 2000 Dec. 15(12):2663-8. [Medline].
Rossetti A, Sizzi O, Soranna L, et al. Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod. 2001 Apr. 16(4):770-4. [Medline].
Alessandri F, Lijoi D, Mistrangelo E, et al. Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. The Journal of Minimally Invasive Gynecology. Mar-Apr 2006. 13:92-97. [Medline].
Fukuda M, Tanaka T, Kamada M, Hayashi A, Yamashita Y, Terai Y. Comparison of the perinatal outcomes after laparoscopic myomectomy versus abdominal myomectomy. Gynecol Obstet Invest. 2013. 76(4):203-8. [Medline].
Corson SL, Brooks PG. Resectoscopic myomectomy. Fertil Steril. 1991 Jun. 55(6):1041-4. [Medline].
Corson SL. Hysteroscopic diagnosis and operative therapy of submucous myoma. Obstet Gynecol Clin North Am. 1995 Dec. 22(4):739-55. [Medline].
Gimpelson RJ. Hysteroscopic treatment of the patient with intracavitary pathology (myomectomy/polypectomy). Obstet Gynecol Clin North Am. 2000 Jun. 27(2):327-37, vii. [Medline].
Emanuel MH, Wamsteker K. The Intra Uterine Morcellator: a new hysteroscopic operating technique to remove intrauterine polyps and myomas. J Minim Invasive Gynecol. Jan-Feb 2005. 12:62-6. [Medline].
Indman PD. Factors affecting capacitive current diversion with a uterine resectoscope: an in vitro study. J Am Assoc Gynecol Laparosc. Feb 2004. 11:128. [Medline].
Indman PD. Hysteroscopic treatment of submucous myomas. Clin Obstet Bynecol. Dec 2006. 49:811-20. [Medline].
Loffer FD. Removal of large symptomatic intrauterine growths by the hysteroscopic resectoscope. Obstet Gynecol. Nov 1990. 76:836-40. [Medline].
Iverson RE Jr, Chelmow D, Strohbehn K, et al. Myomectomy fever: testing the dogma. Fertil Steril. 1999 Jul. 72(1):104-8. [Medline].
LaMorte AI, Lalwani S, Diamond MP. Morbidity associated with abdominal myomectomy. Obstet Gynecol. 1993 Dec. 82(6):897-900. [Medline].
Sawin SW, Pilevsky ND, Berlin JA, Barnhart KT. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. Am J Obstet Gynecol. 2000 Dec. 183(6):1448-55. [Medline].
Frederick J, Hardie M, Reid M, et al. Operative morbidity and reproductive outcome in secondary myomectomy: a prospective cohort study. Hum Reprod. 2002 Nov. 17(11):2967-71. [Medline].
Golan D, Aharoni R, Gonen Y, et al. Early spontaneous rupture of post myomectomy gravid uterus. Int. J. Gynecol. Obstet. Feb 1990. 31:167-170. [Medline].
Ozeren M, Ulusoy M, Uyanik E. First-trimester spontaneous uterine rupture after traditional mymectomy: case report. Isr J Med Sci. Nov 1997. 33:752-753. [Medline].
Roopnarinesingh S, Suratsingh J, Roopnarinesingh A. The obstetric outcome of patients with previous myomectomy or hysterotomy. W.I. Med. J. Mar 1985. 34:59-62. [Medline].
Hockstein S. Spontaneous uterine rupture in the early third trimester after laparoscopically assisted myomectomy. A case report. J Reprod Med. 2000 Feb. 45(2):139-41. [Medline].
Pelosi MA 3rd, Pelosi MA. Spontaneous uterine rupture at thirty-three weeks subsequent to previous superficial laparoscopic myomectomy. Am J Obstet Gynecol. 1997 Dec. 177(6):1547-9. [Medline].
Arcangeli S, Pasquarette MM. Gravid uterine rupture after myolysis. Obstet Gynecol. 1997 May. 89(5 Pt 2):857. [Medline].
Paul P, Koshy A, Thomas T. Pregnancy outcomes following laparoscopic myomectomy and single-layer myometrial closure. Human Reproduction. Dec 2006. 21:3278-3281. [Medline].
Altgassen C, Kuss S, Berger U, et al. Complications in laparoscopic myomectomy. Surgical Endoscopy. Apr 2006. 20:614-618. [Medline].
Kim MS, Uhm YK, Kim JY, Jee BC, Kim YB. Obstetric outcomes after uterine myomectomy: Laparoscopic versus laparotomic approach. Obstet Gynecol Sci. 2013 Nov. 56(6):375-81. [Medline].
Cooper JM, Brady RM. Intraoperative and early postoperative complications of operative hysteroscopy. Obstet Gynecol Clin North Am. 2000 Jun. 27(2):347-66. [Medline].
Emanuel MH, Hart A, Wamsteker K, et al. An analysis of fluid loss during transcervical resection of submucous myomas. Fertil Steril. Nov 1997. 68:881-6. [Medline].
Hallez JP. Single-stage total hysteroscopic myomectomies: indications, techniques, and results. Fertil Steril. 1995 Apr. 63(4):703-8. [Medline].
Vercellini P, Maddalena S, De Giorgi O, et al. Abdominal myomectomy for infertility: a comprehensive review. Hum Reprod. 1998 Apr. 13(4):873-9. [Medline].
Fedele L, Parazzini F, Luchini L, et al. Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study. Hum Reprod. 1995 Jul. 10(7):1795-6. [Medline].
Finn WF, Muller PF. Abdominal myomectomy: special reference to subsequent pregnancy and to the reappearance of fibromyomas of the uterus. Am J Obstet Gynecol. 1950 Jul. 60(1):109-16. [Medline].
Brown AB, Chamberlain R, Te Linde RW. Myomectomy. Am J Obstet Gynecol. 1956 Apr. 71(4):759-63. [Medline].
Malone LJ. Myomectomy: recurrence after removal of solitary and multiple myomas. Obstet Gynecol. 1969 Aug. 34(2):200-3. [Medline].
Berkeley AS, DeCherney AH, Polan ML. Abdominal myomectomy and subsequent fertility. Surg Gynecol Obstet. 1983 Mar. 156(3):319-22. [Medline].
Garcia CR, Tureck RW. Submucosal leiomyomas and infertility. Fertil Steril. 1984 Jul. 42(1):16-9. [Medline].
Rosenfeld DL. Abdominal myomectomy for otherwise unexplained infertility. Fertil Steril. 1986 Aug. 46(2):328-30. [Medline].
Smith DC, Uhlir JK. Myomectomy as a reproductive procedure. Am J Obstet Gynecol. 1990 Jun. 162(6):1476-9; discussion 1479-82. [Medline].
Verkauf BS. Myomectomy for fertility enhancement and preservation. Fertil Steril. 1992 Jul. 58(1):1-15. [Medline].
Gehlbach DL, Sousa RC, Carpenter SE, Rock JA. Abdominal myomectomy in the treatment of infertility. Int J Gynaecol Obstet. 1993 Jan. 40(1):45-50. [Medline].
Acien P, Quereda F. Abdominal myomectomy: results of a simple operative technique. Fertil Steril. 1996 Jan. 65(1):41-51. [Medline].
Stewart EA, Faur AV, Wise LA, et al. Predictors of subsequent surgery for uterine leiomyomata after abdominal myomectomy. Obstet Gynecol. 2002 Mar. 99(3):426-32. [Medline].
Hanafi M. Predictors of leiomyoma recurrence after myomectomy. American College of Obstetricians and Gynecologists. Apr 2005. 105:877-881. [Medline].
Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynaecol. 1991 Apr. 98(4):385-9. [Medline].
Seracchioli R, Manuzzi L, Vianello F, et al. Obstetric and delivery outcome of pregnancies achieved after laparoscopic mymectomy. Fertility and Sterility. Jul 2006. 86:159-165. [Medline].
Cela V, Freschi L, Simi G, Tana R, Russo N, Artini PG. Fertility and endocrine outcome after robot-assisted laparoscopic myomectomy (RALM). Gynecol Endocrinol. 2013 Jan. 29(1):79-82. [Medline].
Pitter MC, Gargiulo AR, Bonaventura LM, Lehman JS, Srouji SS. Pregnancy outcomes following robot-assisted myomectomy. Hum Reprod. 2013 Jan. 28(1):99-108. [Medline].
Doridot V, Dubuisson JB, Chapron C, et al. Recurrence of leiomyomata after laparoscopic myomectomy. J Am Assoc Gynecol Laparosc. 2001 Nov. 8(4):495-500. [Medline].
Taylor E, Gomel V. The uterus and fertility. Fertility and Sterility. Jan 2008. 89:1-16. [Medline].
Goldenberg M, Sivan E, Sharabi Z, et al. Outcome of hysteroscopic resection of submucous myomas for infertility. Fertil Steril. 1995 Oct. 64(4):714-6. [Medline].
Vercellini P, Zaina B, Yaylayan L, et al. Hysteroscopic myomectomy: long-term effects on menstrual pattern and fertility. Obstet Gynecol. 1999 Sep. 94(3):341-7. [Medline].
Fernandez H, Sefrioui O, Virelizier C, et al. Hysteroscopic resection of submucosal myomas in patients with infertility. Hum Reprod. 2001 Jul. 16(7):1489-92. [Medline].
Bernard G, Darai E, Poncelet C, et al. Fertility after hysteroscopic myomectomy: effect of intramural myomas associated. Eur J Obstet Gynecol Reprod Biol. 2000 Jan. 88(1):85-90. [Medline].
Shokeir TA. Hysteroscopic management in submucous fibroids to improve fertility. Arch Gynecol Obstet. 2005 Nov. 273(1):50-4. [Medline].
Litta P, Conte L, De Marchi F, Saccardi C, Angioni S. Pregnancy outcome after hysteroscopic myomectomy. Gynecol Endocrinol. 2013 Dec 5. [Medline].
Emanuel MH, Wamsteker K, Hart AA, et al. Long-term results of hysteroscopic myomectomy for abnormal uterine bleeding. Obstet Gynecol. 1999 May. 93(5 Pt 1):743-8. [Medline].
Hart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol. 1999 Jul. 106(7):700-5. [Medline].
Donnez J, Nisolle M, Clerckx F, et al. Advanced endoscopic techniques used in dysfunctional bleeding, fibroids and endometriosis, and the role of gonadotrophin-releasing hormone agonist treatment. Br J Obstet Gynaecol. 1994 May. 101 Suppl 10:2-9. [Medline].
Metwally M, Cheong YC, Horne AW. Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev. 2012 Nov 14. 11:CD003857. [Medline].
Ben-Baruch G, Schiff E, Menashe Y, Menczer J. Immediate and late outcome of vaginal myomectomy for prolapsed pedunculated submucous myoma. Obstet Gynecol. 1988 Dec. 72(6):858-61. [Medline].
Ligon AH, Morton CC. Genetics of uterine leiomyomata. Genes Chromosomes Cancer. 2000 Jul. 28(3):235-45. [Medline].
Myomas and reproductive function. Fertil Steril. 2008 Nov. 90(5 Suppl):S125-30. [Medline].
Nkemayim DC, Hammadeh ME, Hippach M, et al. Uterine rupture in pregnancy subsequent to previous laparoscopic electromyolysis. Case report and review of the literature. Arch Gynecol Obstet. 2000 Nov. 264(3):154-6. [Medline].

Media Gallery

Small uterine myomas visualized at laparoscopy.
Submucosal myoma visualized at hysteroscopy.
Submucosal myoma being resected hysteroscopically with a loop resectoscope.
Hysteroscopic myomectomy. A 24-year-old woman with menorrhagia and severe anemia in whom hormonal treatment failed. Sonohysterography showed multiple submucosal fibroids. She underwent hysteroscopic myomectomy after administration of Depo-Lupron. Part 1. Video courtesy of Tarek Bardawil, MD.
Hysteroscopic myomectomy. A 24-year-old woman with menorrhagia and severe anemia in whom hormonal treatment failed. Sonohysterography showed multiple submucosal fibroids. She underwent hysteroscopic myomectomy after administration of Depo-Lupron. Part 2. Video courtesy of Tarek Bardawil, MD.
Robotic myomectomy. A 32-year-old woman was found to have a large fibroid during pregnancy. Postpartum, the fibroid caused pelvic pain and dyspareunia. Pelvic ultrasonography revealed a 10-cm fundal transmural fibroid. Part 1. Video courtesy of Tarek Bardawil, MD.
Robotic myomectomy. A 32-year-old woman was found to have a large fibroid during pregnancy. Postpartum, the fibroid caused pelvic pain and dyspareunia. Pelvic ultrasonography revealed a 10-cm fundal transmural fibroid. Part 2. Video courtesy of Tarek Bardawil, MD.
Intramural myoma.
Pedunculated myoma.
Myoma identified on vaginal ultrasound.

of 10

Table 1. Summary of Studies Reporting Need for Future Surgery for Myomas After Myomectomy

Study	Year	Follow-up, mo	Reoperation Rate
Finn and Muller^[100]	1950	24-120+	13%
Brown et al^[101]	1956	>72	17%
Malone^[102]	1969	>60	27%
Berkeley et al^[103]	1983	17	8%
Garcia and Tureck^[104]	1984	>10	6%
Rosenfeld^[105]	1986	>12	4%
Smith and Uhlir^[106]	1990	NR	5%
Verkauf^[107]	1992	42	6%
Gehlbach et al^[108]	1993	>12	12%
Acien and Querada^[109]	1996	4-144	8%
Stewart et al^[110]	2002	84 ± 35	35%
Hanafi^[111]	2005	2-136	17%

Table 2. Pregnancy Rates in Patients Undergoing Hysteroscopic Myomectomy

Author	Year	Study Size	Pregnancy Rate

Goldenberg et al^[118]	1995	15	47%
Vercellini et al^[119]	1999	40	37%
Fernandez et al^[120]	2001	59	27%
Bernard et al^[121]	2000	31	35%
Shokeir^[122]	2005	29	72%
Litta^[123]	2013	104	86%

Back to List

Author

Sarah Hagood Milton, MD Resident Physician, Department of Obstetrics and Gynecology, Virginia Commonwealth University Health System

Disclosure: Nothing to disclose.

Coauthor(s)

David Chelmow, MD Leo J Dunn Professor and Chair, Department of Obstetrics and Gynecology, Virginia Commonwealth University Medical Center

David Chelmow, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, American Society for Colposcopy and Cervical Pathology, Association of Professors of Gynecology and Obstetrics, Council of University Chairs of Obstetrics and Gynecology, Phi Beta Kappa, Sigma Xi, The Scientific Research Honor Society, Society for Academic Specialists in General Obstetrics and Gynecology, Society for Reproductive Investigation

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Michel E Rivlin, MD Former Professor, Department of Obstetrics and Gynecology, University of Mississippi School of Medicine

Michel E Rivlin, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Medical Association, Mississippi State Medical Association, Royal College of Surgeons of Edinburgh, Royal College of Obstetricians and Gynaecologists

Disclosure: Nothing to disclose.

Additional Contributors

Thomas Michael Price, MD Associate Professor, Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Director of Reproductive Endocrinology and Infertility Fellowship Program, Duke University Medical Center

Thomas Michael Price, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Obstetricians and Gynecologists, Phi Beta Kappa, Society for Reproductive Investigation, Society for Reproductive Endocrinology and Infertility, American Society for Reproductive Medicine

Disclosure: Received research grant from: Insigtec Inc<br/>Received consulting fee from Clinical Advisors Group for consulting; Received consulting fee from MEDA Corp Consulting for consulting; Received consulting fee from Gerson Lehrman Group Advisor for consulting; Received honoraria from ABOG for board membership.

Acknowledgements

Medscape Reference thanks Tarek Bardawil, MD, Assistant Professor, Department of Obstetrics and Gynecology, University of Miami Miller School of Medicine, for assistance with the video contribution to this article.

Gynecologic Myomectomy Workup

Diagnostic Studies and Procedures

Laboratory studies

Imaging studies

Diagnostic procedure

References

Tables

Contributor Information and Disclosures

What would you like to print?